Skip to main content
Clinical Trials/CTRI/2020/12/029965
CTRI/2020/12/029965Not yet recruiting未知

Investigating the role of nicotinic neuromodulation in levodopa-induced dyskinesias â?? a multimodal study.

ational Brain Research Centre0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • non-smoker ( >10 years)
  • - able to provide informed consent

Exclusion Criteria

  • The subjects may not be eligible to participate if he/she -
  • -Has any neurological disorder (except PD in the patient group)
  • -Has a current depressive episode, schizophrenia or bipolar disorder (self-declared and screened with GHQ-12 (Goldberg et al., 1978; Qin et al., 2018))
  • -Has had any head injury with loss of consciousness
  • - Has had any seizures in the past
  • -Has cognitive impairment (Mini Mental Status Examination (MMSE) test score <25)
  • -Abuses drugs/alcohol
  • -Is pregnant or nursing
  • Subjects will not be eligible for MRI scanning if they -
  • -Have non-MRI compatible metal in the body such as a cardiac pacemaker, brain stimulator, surgical metal, cochlear implants, artificial heart valves or dental implants.
  • -Are unable to lie flat on the back for the duration of the scan.
  • -Have uncontrollable head movements.
  • -Are claustrophobic.
  • Subjects will not be eligible to undergo TMS if they â??
  • -Have metal implants in the body such as brain stimulator, surgical metal, cochlear implants, cardiac pacemaker, intracardiac lines, implanted pumps or stimulators.

Investigators

Sponsor
ational Brain Research Centre

Similar Trials